Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation
Abstract Background Pulmonary vein isolation (PVI) using conventional power (30–35 W) radiofrequency ablation (RFA) has been an effective treatment strategy for paroxysmal atrial fibrillation (PAF), but its longer duration may cause collateral damage to peripheral tissue including esophageal and phr...
| الحاوية / القاعدة: | BMC Cardiovascular Disorders |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
BMC
2025-03-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s12872-025-04597-9 |
| _version_ | 1849495695022620672 |
|---|---|
| author | Xinzhong Li Zhiwen Xiao Jiachen Zhang Xiaobo Huang Hairuo Lin Senlin Huang Yulin Liao Juefei Wu Jiancheng Xiu Jianyong Li Jianping Bin Yuegang Wang |
| author_facet | Xinzhong Li Zhiwen Xiao Jiachen Zhang Xiaobo Huang Hairuo Lin Senlin Huang Yulin Liao Juefei Wu Jiancheng Xiu Jianyong Li Jianping Bin Yuegang Wang |
| author_sort | Xinzhong Li |
| collection | DOAJ |
| container_title | BMC Cardiovascular Disorders |
| description | Abstract Background Pulmonary vein isolation (PVI) using conventional power (30–35 W) radiofrequency ablation (RFA) has been an effective treatment strategy for paroxysmal atrial fibrillation (PAF), but its longer duration may cause collateral damage to peripheral tissue including esophageal and phrenic nerve. High-power (HP) RFA, due to better transmural performance and shorter duration, may reduce the damage to adjacent tissue and is expected to be a safe and efficient ablation strategy. Methods In this retrospective cohort study, we included 259 patients with PAF who underwent lesion size index (LSI)-guided radiofrequency ablation. All patients underwent PVI-based ablation, and some underwent additional ablation, including superior vena cava isolation, tricuspid isthmus block, or left anterior atrial matrix modification. A total of 119 PAF patients underwent 50 W ablation. Complications and twelve-month arrhythmia-free outcomes of the procedure were compared with those of 140 patients who underwent 30–35 W ablation. Results PVI was successfully achieved in all patients. The procedural duration (140.3 ± 34.4 vs. 151.3 ± 40.6 min, P = 0.022) and overall radiation (112.0 ± 67.2 vs. 188.2 ± 119.2 mGy·cm2, P < 0.001) were significantly lower in the 50 W group. No major complications occurred in the high-power short-duration (HPSD) group, whereas in the conventional power group, five participants developed complications. Among them, three cases were related to venipuncture, one had pericardial tamponade, and one had slight pericardial effusion. The recurrence of arrhythmia at the twelve-month follow-up was not significantly different between the two groups [11 (9.2%) vs. 19 (13.6%), P = 0.278]. Conclusion LSI-guided HPSD-RFA was demonstrated to be comparably safe and efficacious compared to conventional ablation and resulted in reduced procedure time and radiation exposure. Graphical Abstract Central Illustration. Safety and Efficacy of Lesion Size Index Guided 50 W Radiofrequency ablation in Patients with Paroxysmal Atrial Fibrillation. A total of 259 patients with paroxysmal atrial fibrillation underwent lesion size index (LSI)-guided radiofrequency ablation were enrolled. High-Power Short-Duration ablation reduced total procedure time, significantly decreased radiation exposure, and had similar recurrence rate of atrial fibrillation. |
| format | Article |
| id | doaj-art-e0434aed27b74bf1a7eaaffb11ead17c |
| institution | Directory of Open Access Journals |
| issn | 1471-2261 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | BMC |
| record_format | Article |
| spelling | doaj-art-e0434aed27b74bf1a7eaaffb11ead17c2025-08-20T03:05:57ZengBMCBMC Cardiovascular Disorders1471-22612025-03-0125111010.1186/s12872-025-04597-9Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillationXinzhong Li0Zhiwen Xiao1Jiachen Zhang2Xiaobo Huang3Hairuo Lin4Senlin Huang5Yulin Liao6Juefei Wu7Jiancheng Xiu8Jianyong Li9Jianping Bin10Yuegang Wang11Department of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityClinical Research Center, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityDepartment of Cardiology, Nanfang Hospital, Southern Medical UniversityAbstract Background Pulmonary vein isolation (PVI) using conventional power (30–35 W) radiofrequency ablation (RFA) has been an effective treatment strategy for paroxysmal atrial fibrillation (PAF), but its longer duration may cause collateral damage to peripheral tissue including esophageal and phrenic nerve. High-power (HP) RFA, due to better transmural performance and shorter duration, may reduce the damage to adjacent tissue and is expected to be a safe and efficient ablation strategy. Methods In this retrospective cohort study, we included 259 patients with PAF who underwent lesion size index (LSI)-guided radiofrequency ablation. All patients underwent PVI-based ablation, and some underwent additional ablation, including superior vena cava isolation, tricuspid isthmus block, or left anterior atrial matrix modification. A total of 119 PAF patients underwent 50 W ablation. Complications and twelve-month arrhythmia-free outcomes of the procedure were compared with those of 140 patients who underwent 30–35 W ablation. Results PVI was successfully achieved in all patients. The procedural duration (140.3 ± 34.4 vs. 151.3 ± 40.6 min, P = 0.022) and overall radiation (112.0 ± 67.2 vs. 188.2 ± 119.2 mGy·cm2, P < 0.001) were significantly lower in the 50 W group. No major complications occurred in the high-power short-duration (HPSD) group, whereas in the conventional power group, five participants developed complications. Among them, three cases were related to venipuncture, one had pericardial tamponade, and one had slight pericardial effusion. The recurrence of arrhythmia at the twelve-month follow-up was not significantly different between the two groups [11 (9.2%) vs. 19 (13.6%), P = 0.278]. Conclusion LSI-guided HPSD-RFA was demonstrated to be comparably safe and efficacious compared to conventional ablation and resulted in reduced procedure time and radiation exposure. Graphical Abstract Central Illustration. Safety and Efficacy of Lesion Size Index Guided 50 W Radiofrequency ablation in Patients with Paroxysmal Atrial Fibrillation. A total of 259 patients with paroxysmal atrial fibrillation underwent lesion size index (LSI)-guided radiofrequency ablation were enrolled. High-Power Short-Duration ablation reduced total procedure time, significantly decreased radiation exposure, and had similar recurrence rate of atrial fibrillation.https://doi.org/10.1186/s12872-025-04597-9Paroxysmal atrial fibrillationHigh-power short-duration ablationPulmonary vein isolationRadiofrequency ablation |
| spellingShingle | Xinzhong Li Zhiwen Xiao Jiachen Zhang Xiaobo Huang Hairuo Lin Senlin Huang Yulin Liao Juefei Wu Jiancheng Xiu Jianyong Li Jianping Bin Yuegang Wang Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation Paroxysmal atrial fibrillation High-power short-duration ablation Pulmonary vein isolation Radiofrequency ablation |
| title | Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation |
| title_full | Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation |
| title_fullStr | Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation |
| title_full_unstemmed | Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation |
| title_short | Safety and efficacy of lesion size index guided 50 W radiofrequency ablation in patients with paroxysmal atrial fibrillation |
| title_sort | safety and efficacy of lesion size index guided 50 w radiofrequency ablation in patients with paroxysmal atrial fibrillation |
| topic | Paroxysmal atrial fibrillation High-power short-duration ablation Pulmonary vein isolation Radiofrequency ablation |
| url | https://doi.org/10.1186/s12872-025-04597-9 |
| work_keys_str_mv | AT xinzhongli safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT zhiwenxiao safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT jiachenzhang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT xiaobohuang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT hairuolin safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT senlinhuang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT yulinliao safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT juefeiwu safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT jianchengxiu safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT jianyongli safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT jianpingbin safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation AT yuegangwang safetyandefficacyoflesionsizeindexguided50wradiofrequencyablationinpatientswithparoxysmalatrialfibrillation |
